The Regulation of Artificial Intelligence on Issues Related to Medically Assisted Reproduction

Abstract

Medically assisted reproduction techniques do not escape the new tendency to automate medical processes due to the vertiginous advances of bioengineering. The
main objective of automating in vitro fertilization is to be able to perform many more treatments at a lower cost. In addition, better results are less the cycles to which
patients should be submitted. An issue that emerges in the field of reproductive medicine is that artificial intelligence (AI) applications could quickly begin to be
operated by people who have no specific knowledge in this branch of medicine. In turn, the number of biologists specialized in embryology necessary in laboratories
could be diminished, who would lose their job if they were not trained in the use of AI. It is likely that the occupational market will be redirect and the new graduates
turn more to that type of formation. However, the human factor remains an important value for the trust that the patient deposits in the medical professional who
advises and reassures him. Recall that in assisted fertility treatments this is carried out more by doctors specializing in reproductive medicine than by embryologists